Do uterotrophic drugs increase the risk of fatal hemorrhagic brain stroke?

Takashi Yamada 1 , Takahiro Yamada 1 , Mamoru Morikawa 1 , Masamitsu Takeda 1 , Rina Akaishi 1 , Ryutaro Nishida 1 , Naoto Araki 1 , Takahiro Koyama 1  and Hisanori Minakami 1
  • 1 Department of Obstetrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan


Objective: To evaluate whether uterotrophic agents increase the risk of fatal hemorrhagic brain stroke.

Methods: Between 1991 and 1992, there were 230 maternal deaths among 2,420,000 pregnant women in Japan and the causes of these deaths was investigated in 1994. Using information provided in this report, we identified 35 women who died from or were assumed to die from hemorrhagic brain stroke. We assumed that 93% of women would have tried vaginal delivery. The risk of fatal hemorrhagic brain stroke after uterotrophic agent use was calculated according to the assumption that 5.0–40% of women received uterotrophic agents.

Results: Use of uterotrophic agents for induction/augmentation of labor was confirmed in five (14.3%) of the 35 women who died from hemorrhagic brain stroke. The incidence of fatal brain stroke after the use of uterotrophic agents was only significantly higher than that for spontaneous hemorrhagic brain stroke if these agents were administered in ≤6.0% of women.

Conclusions: Because more than 6.0% of women received uterotrophic agents, these agents are unlikely to increase the risk of fatal hemorrhagic brain stroke.

Purchase article
Get instant unlimited access to the article.
Log in
Already have access? Please log in.

Log in with your institution

Journal + Issues

The Journal of Perinatal Medicine is a truly international forum covering the entire field of perinatal medicine. It is an essential news source for all those obstetricians, neonatologists, perinatologists and allied health professionals who wish to keep abreast of progress in perinatal and related research.